Keywords: Joran, Qatar, Pharma markets, drug price controls, Generics, BMI

Growth prospects for Jordan and Qatar pharmaceuticals markets assessed by BMI

Article | 24 March 2011

After shrinking by 8.5% in 2009, Business Monitor International forecasts a return to growth in 2010, up 7.4% to 307 million Jordanian dinars ($433 million) for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in